Lv5
1182 积分 2025-05-16 加入
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Lipoprotein(a)-lowering therapies: a promising future
7天前
已完结
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
7天前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
28天前
已完结
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook
1个月前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
1个月前
已完结
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
1个月前
已完结
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
1个月前
已完结
Mechanisms and treatment of pulmonary arterial hypertension
1个月前
已完结
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin
1个月前
已完结
皖公网安备34019202002308
